Agenus | AGEN - Ebitda





Ebitda Veränderung Datum
AbbVie USD 5.37B 1.85B 2025-12
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Celldex Therapeutics USD -83.58M 2.76M 2026-03
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Incyte USD 367.97M 46.53M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 7.19B 2.32B 2025-12
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck EUR 1.53B 87M 2026-03
Merck USD 6.3B 2.09B 2025-12
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Novartis USD 5.3B 530M 2026-03
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 42.8M 488K 2026-03